The bipartisan U.S. House Task Force on Artificial Intelligence (AI) its highly anticipated on AI Dec. 17. The nonbinding report is intended to inform policymaking activities and priorities of the next Congress and covers a broad range of cross-cutting and sector-specific issues, including those related to the healthcare sector. The 黑料网® (黑料网®) met with congressional offices and provided comments in May to inform the task force’s efforts.
In general, the task force supports leveraging and expanding the authorities of existing regulatory agencies within the specific sectors instead of creating a centralized AI agency. With regard to healthcare, the task force recommends:
- Ensuring AI safety/transparency, particularly for AI that denies or approves care/coverage.
- Supporting the National Institutes of Health and other agencies’ research into healthcare AI.
- Creating incentives to ensure appropriate risk management practices.
- Exploring the expansion of U.S. Food and Drug Administration authority to add to post-market monitoring capabilities.
- Examining relevant liability laws and standards.
- Supporting appropriate payment mechanisms.
For more information about 黑料网’s AI-related programs and initiatives, visit the . For questions about AI oversight policy, contact Michael Peters, 黑料网 Senior Director, Government Affairs.